RT @NIAIDNews
COVID-19 NEWS: #SARSCoV2 infection weakens a key immune cell’s response to vaccination with the Pfizer-BioNTech #COVID19 vaccine, suggesting a need to boost this response after infection, #NIAID grantees report: https://bit.ly/40kE5WV

#immunology #Tcells @StanfordMed